Jeffrey Poulton
Director of Finance/CFO bei ALNYLAM PHARMACEUTICALS, INC.
Vermögen: 4 Mio $ am 31.03.2024
Profil
Herr Jeffrey V. Poulton ist ein unabhängiger Direktor bei Homology Medicines, Inc. und Chief Financial & Accounting Officer bei Alnylam Pharmaceuticals, Inc. Er ist Mitglied des Board of Directors bei Homology Medicines, Inc., Alnylam UK Ltd. und EIP Pharma, Inc. Herr Poulton war zuvor als Chief Financial Officer bei Indigo Agriculture, Inc. und als Chief Financial Officer & Executive Director bei Shire Plc. beschäftigt. Er erhielt seinen Bachelor-Abschluss von der Duke University und einen MBA von der Kelley School of Business.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
01.03.2024 | 27 276 ( 0,02% ) | 4 Mio $ | 31.03.2024 | |
CERVOMED INC.
-.--% | 16.08.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
-.--% | 14.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Jeffrey Poulton
Unternehmen | Position | Beginn |
---|---|---|
ALNYLAM PHARMACEUTICALS, INC. | Director of Finance/CFO | 13.08.2019 |
CERVOMED INC. | Director/Board Member | 16.08.2023 |
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Director/Board Member | - |
Alnylam UK Ltd.
Alnylam UK Ltd. BiotechnologyHealth Technology Founded in 2002, Alnylam UK Ltd. is a subsidiary of Alnylam Pharmaceuticals, Inc. that develops biotechnology products. The private company is based in Maidenhead, UK. | Director/Board Member | 13.08.2019 |
Ehemalige bekannte Positionen von Jeffrey Poulton
Unternehmen | Position | Ende |
---|---|---|
Indigo Ag, Inc.
Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Director of Finance/CFO | 01.04.2019 |
SHIRE | Director of Finance/CFO | 31.12.2017 |
Q32 BIO INC. | Director/Board Member | - |
Ausbildung von Jeffrey Poulton
Duke University | Undergraduate Degree |
Kelley School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
CERVOMED INC. | Commercial Services |
Private Unternehmen | 5 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Health Technology |
Homology Medicines, Inc.
Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
Alnylam UK Ltd.
Alnylam UK Ltd. BiotechnologyHealth Technology Founded in 2002, Alnylam UK Ltd. is a subsidiary of Alnylam Pharmaceuticals, Inc. that develops biotechnology products. The private company is based in Maidenhead, UK. | Health Technology |
Indigo Ag, Inc.
Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Health Technology |